Sirtex Microspheres to Be Studied for Cholangiocarcinoma in SIRCCA and Included in ESMO Guidelines

October 11, 2016—Sirtex Medical Ltd announced the commencement of SIRCCA (Selective Internal Radiation Therapy [SIRT] in Cholangiocarcinoma), a phase 2 study of the company’s SIR-Spheres yttrium-90 (Y-90) resin microspheres in patients with unresectable intrahepatic cholangiocarcinoma (iCCA). According to Sirtex, SIRCCA is a prospective multicenter randomized controlled clinical study evaluating SIRT with the company’s microspheres before cisplatin-gemcitabine (CIS-GEM) chemotherapy…

Details

RESIRT Data on Sirtex’s SIR-Spheres to Treat Renal Cell Carcinoma Presented at ESMO Congress

October 10, 2016—Sirtex Medical Inc. announced that the initial safety and efficacy results from the RESIRT pilot clinical study were presented in a poster session at the 2016 European Society for Medical Oncology (ESMO) Congress held October 7–11 in Copenhagen, Denmark. The Australian-based RESIRT study is a single-arm, dose-escalation study of the company’s SIR-Spheres yttrium-90…

Details

Cramping Leg Pain Doctors in Dallas Explain Things You Should Know About Peripheral Artery Disease (PAD)

Peripheral Arterial Disease (PAD) is a common circulatory problem in which the arteries that carry blood to your head, organs, and limbs become narrowed by the buildup of arterial plaque (atherosclerosis), significantly reducing blood flow to your extremities. This reduced blood flow can cause cramping pain, numbness, achiness, and feelings of heaviness in the legs,…

Details